Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Accumulated Expenses (2016 - 2025)

Proto Labs' Accumulated Expenses history spans 15 years, with the latest figure at $26.8 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 61.83% year-over-year to $26.8 million; the TTM value through Dec 2025 reached $26.8 million, up 61.83%, while the annual FY2025 figure was $26.8 million, 61.83% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $26.8 million at Proto Labs, down from $27.8 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $27.8 million in Q3 2025 and bottomed at $11.7 million in Q1 2021.
  • The 5-year median for Accumulated Expenses is $16.6 million (2022), against an average of $18.4 million.
  • The largest annual shift saw Accumulated Expenses skyrocketed 96.08% in 2022 before it tumbled 36.19% in 2023.
  • A 5-year view of Accumulated Expenses shows it stood at $13.7 million in 2021, then surged by 63.34% to $22.4 million in 2022, then plummeted by 31.68% to $15.3 million in 2023, then grew by 8.23% to $16.6 million in 2024, then soared by 61.83% to $26.8 million in 2025.
  • Per Business Quant, the three most recent readings for PRLB's Accumulated Expenses are $26.8 million (Q4 2025), $27.8 million (Q3 2025), and $25.8 million (Q2 2025).